Tenax Therapeutics, Inc. TENX
1.81
(0.08)
(4.23%)
as of 25 Sep
- Market cap
- $70.0M
- P/E
- 0.0×
Follow TENX
Insider Buys
alert about insiders buying in the last 12 month
| Dec '25 | Dec '24 | Dec '23 | Dec '22 | Dec '21 | Dec '20 | Dec '19 | Dec '18 | Dec '17 | Dec '16 | |
|---|---|---|---|---|---|---|---|---|---|---|
Current Ratio |
14.57 | 20.60 | 3.26 | 1.74 | 3.64 | 3.21 | 2.44 | 8.51 | 7.99 | 2.20 |
Net Debt/EBITDA |
1.73 | 4.87 | 1.19 | 0.19 | 0.17 | 0.69 | 0.64 | 1.89 | 0.86 | 0.26 |
Debt/Assets |
0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% |
Debt/Equity |
0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
Asset Turnover |
0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
Operating CF/Net income |
0.68 | 0.84 | 0.77 | 1.03 | 0.33 | 0.94 | 0.90 | 0.39 | 1.37 | 0.36 |
Capex/Depreciation |
— | — | 0.38 | (0.02) | (0.04) | (0.03) | (0.03) | (0.08) | (0.02) | 0.11 |
Interest Coverage |
0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| (55.64%) | (35.17%) | (160.80%) | (385.12%) | (732.21%) | (234.61%) | (108.01%) | (136.97%) | (67.94%) | (113.26%) | |
| (52.36%) | (32.48%) | (102.20%) | (235.14%) | (505.01%) | (148.88%) | (85.21%) | (121.79%) | (53.20%) | (91.20%) | |
ROIC |
0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | (498.28%) | (852.44%) |
Return on Tangible Assets |
(54.19%) | (19.13%) | (95.23%) | (807.65%) | (785.91%) | (210.39%) | (229.67%) | (120.24%) | (125.14%) | (589.73%) |
Average Days of Receivables |
— | — | — | — | — | — | — | — | 0.00 | 0.00 |
Research and Development Expense of Revenue |
0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% |
Selling, General and Administrative Expense of Revenue |
0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% |
Intangible Assets out of Total Assets |
0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
Share Based Compensation of Revenue |
0.00% | 0.00% | 0.00% | — | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% |
Free Cash Flow per Share |
(0.91) | (0.97) | (23.79) | (619.07) | (841.98) | (1,427.14) | (1,938.41) | (5,507.10) | (13,494.44) | (17,554.67) |
Cash per Share |
2.49 | 6.21 | 39.48 | 115.42 | 432.86 | 1,032.75 | 1,384.59 | 12,862.00 | 8,585.78 | 14,756.22 |
Shareholders Equity per Share |
2.48 | 6.02 | 32.65 | 81.13 | 329.05 | 711.63 | 967.31 | 11,771.50 | 9,868.78 | 19,045.44 |
Interest Debt per Share |
0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
Book value per Share |
2.48 | 6.02 | 32.65 | 81.13 | 329.05 | 711.63 | 967.31 | 11,771.50 | 9,868.78 | 19,045.44 |
Free Cash Flow |
(35.80) | (14.81) | (5.90) | (11.39) | (10.86) | (9.28) | (7.56) | (5.51) | (12.14) | (15.80) |
Working Capital |
97.07 | 91.99 | 8.10 | 1.36 | 4.13 | 4.68 | 3.65 | 11.75 | 7.05 | 7.43 |
Capital Expenditures |
— | — | 0.00 | 0.00 | (0.01) | 0.00 | 0.00 | (0.01) | 0.00 | 0.07 |
Net Current Asset Value |
97.07 | 91.99 | 8.10 | 1.30 | 3.94 | 4.55 | 3.59 | 11.75 | 7.05 | 7.43 |
| Other line items | ||||||||||
Quick Ratio |
13.63 | 20.21 | 2.73 | 1.15 | 3.57 | 3.17 | 2.13 | 8.21 | 7.71 | 2.15 |
Depreciation/Fixed assets |
— | — | 0.00 | 15.74 | 16.68 | 20.30 | 16.06 | 11.82 | 20.31 | 35.17 |
Cash ROIC |
(18.39%) | (7.93%) | (33.00%) | (315.11%) | (110.53%) | (81.84%) | (82.45%) | (22.36%) | (73.16%) | (52.23%) |
Accounts Receivable Turnover |
— | — | — | — | — | — | — | — | 0.00 | 0.00 |
Accounts Payable Turnover |
0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
Inventory Turnover |
— | — | — | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
Average Days of Payables |
0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
Days of Inventory on Hand |
— | — | — | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
Revenue per Share |
0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
Operating CF per Share |
(0.91) | (0.97) | (23.81) | (618.95) | (841.57) | (1,426.60) | (1,937.49) | (5,499.50) | (13,489.44) | (17,634.78) |
Capex per Share |
0.00 | 0.00 | 0.01 | (0.12) | (0.41) | (0.54) | (0.92) | (7.60) | (5.00) | 80.11 |
Average Receivables |
— | — | — | — | — | — | — | — | 0.06 | 0.06 |
Average Payables |
4.60 | 2.62 | 1.26 | 0.65 | 0.81 | 1.21 | 1.21 | 0.68 | 0.67 | 0.85 |
Average Assets |
100.46 | 54.19 | 7.54 | 4.70 | 6.43 | 6.62 | 9.85 | 11.61 | 16.62 | 48.16 |
Average Common Equity |
94.53 | 50.05 | 4.80 | 2.87 | 4.44 | 4.20 | 7.77 | 10.33 | 13.01 | 38.78 |
Capex to Sales |
— | — | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
Net Profit Margin |
0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% |
Columns are period end dates